High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: A randomized controlled study

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 4, 2012, Pages 590-596

  Dani, C ^a   Vangi, V ^a   Bertini, G ^a   Pratesi, S ^a   Lori, I ^a   Favelli, F ^a   Ciuti, R ^a   Bandinelli, A ^a   Martano, C ^b   Murru, P ^b   Messner, H ^c   Schena, F ^d   Mosca, F ^d  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Neonatal Intensive Care Unit of Ospedale Regionale   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN;

ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NEWBORN; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME;

DOSE-RESPONSE RELATIONSHIP, DRUG; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE;

EID: 84858795539     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.284     Document Type: Article

References (28)

1. Van Overmeire, B. et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N. Engl. J. Med. 343, 674-681 (2000).
2. Hamrick, S.E. & Hansmann, G. Patent ductus arteriosus of the preterm infant. Pediatrics 125, 1020-1030 (2010).
3. Itabashi, K., Ohno, T. & Nishida, H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. J. Pediatr. 143, 203-207 (2003). (Pubitemid 37082952)
4. Ohlsson, A., Walia, R. & Shah, S.S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst. Rev. CD003481 (2010).
5. Gournay, V. et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 364, 1939-1944 (2004). (Pubitemid 39574596)
6. Sperandio, M. et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 116, 1361-1366 (2005). (Pubitemid 46056483)
7. Desfrere, L. et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J. Clin. Pharm. Ther. 30, 121-132 (2005). (Pubitemid 41583606)
8. Hirt, D. et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br. J. Clin. Pharmacol. 65, 629-636 (2008). (Pubitemid 351535097)
9. Van Overmeire, B., Touw, D., Schepens, P.J., Kearns, G.L. & van den Anker, J.N. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin. Pharmacol. Ther. 70, 336-343 (2001). (Pubitemid 33022474)
10. Seyberth, H.W., Knapp, G., Wolf, D. & Ulmer, H.E. Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus. Eur. J. Pediatr. 141, 71-76 (1983). (Pubitemid 14249517)
11. Aranda, J.V. et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr. 86, 289-293 (1997). (Pubitemid 27135276)
12. Treluyer, J.M., Gueret, G., Cheron, G., Sonnier, M. & Cresteil, T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7, 441-452 (1997). (Pubitemid 27517572)
13. Richards, J., Johnson, A., Fox, G. & Campbell, M. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 124, e287-e293 (2009).
14. Fanos, V., Antonucci, R. & Zaffanello, M. Ibuprofen and acute kidney injury in the newborn. Turk. J. Pediatr. 52, 231-238 (2010).
15. Ahlfors, C.E. Effect of ibuprofen on bilirubin-albumin binding. J. Pediatr. 144, 386-388 (2004). (Pubitemid 38333899)
16. Reese, J., Veldman, A., Shah, L., Vucovich, M. & Cotton, R.B. Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period. Semin. Perinatol. 34, 222-230 (2010).
17. Bökenkamp, R., DeRuiter, M.C., van Munsteren, C. & Gittenberger-de Groot, A.C. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus. Neonatology 98, 6-17 (2010).
18. Bhandari, V. et al. Genetic contribution to patent ductus arteriosus in the premature newborn. Pediatrics 123, 669-673 (2009).
19. Dagle, J.M. et al. Determination of genetic predisposition to patent ductus arteriosus in preterm infants. Pediatrics 123, 1116-1123 (2009).
20. Rey, E. et al. Stereoselective disposition of ibuprofen enantiomers in infants. Br. J. Clin. Pharmacol. 38, 373-375 (1994). (Pubitemid 24314694)
21. Varvarigou, A., Bardin, C.L., Beharry, K., Chemtob, S., Papageorgiou, A. & Aranda, J.V. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275, 539-544 (1996). (Pubitemid 26061429)
22. Papile, L.A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529-534 (1978). (Pubitemid 8293290)
23. de Vries, L.S., Eken, P. & Dubowitz, L.M. The spectrum of leukomalacia using cranial ultrasound. Behav. Brain Res. 49, 1-6 (1992).
24. Ehrenkranz, R.A. et al.; National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116, 1353-1360 (2005). (Pubitemid 46056482)
25. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch. Ophthalmol. 123, 991-999 (2005).
26. Bell, M.J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann. Surg. 187, 1-7 (1978).
27. American Academy of Pediatric's Committee on drugs, Committee on fetus and newborn and Committee on Infectious Diseases. Pediatrics 65, 1047-1053 (1980).
28. Brissaud, O. & Guichoux, J. Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units. Pediatr. Cardiol. 32, 607-614 (2011).